03:52 PM EST, 11/13/2025 (MT Newswires) -- Novo Nordisk ( NVO ) and Eli Lilly ( LLY ) said they have no partnership or special arrangement with Mangoceuticals ( MGRX ) , disputing a press release from the telehealth firm that claimed ties to their obesity drugs, Reuters reported Thursday, citing emailed statements from Novo Nordisk ( NVO ) and Eli Lilly ( LLY ) spokespeople.

Shares of Mangoceuticals ( MGRX ) were down nearly 37% in recent Thursday trading.

Novo Nordisk ( NVO ), Eli Lilly ( LLY ), and Mangoceuticals ( MGRX ) did not immediately respond to MT Newswires' request for comment on the matter.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 49.03, Change: -1.24, Percent Change: -2.46